Drug Search Results
More Filters [+]

glutathione

Alternative Names: glutathione
Latest Update: 2024-11-05
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Peptide/Protein

Route of Administration: Oral,Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Australia | Austria | Bulgaria | Chile | China | Ecuador | France | Greece | Hong Kong | India | Ireland | Italy | Korea | Malaysia | Peru | Philippines | Poland | Russia | South Africa | Spain | Sweden | Taiwan | Ukraine | United Arab Emirates | United Kingdom | United States | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for glutathione

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events